




Searching News Database: HPV Vaccine
HSMN NewsFeed - 20 Jan 2022
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
HSMN NewsFeed - 17 Feb 2010
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
HSMN NewsFeed - 20 May 2008
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection from Cervical Disease than the Pap
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection from Cervical Disease than the Pap
HSMN NewsFeed - 14 May 2008
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
HSMN NewsFeed - 10 Mar 2008
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 29 Sep 2006
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 27 Feb 2006
AVANT Announces that the European Regulatory Authorities Have Approved Rotarix(R) Rotavirus Vaccine
AVANT Announces that the European Regulatory Authorities Have Approved Rotarix(R) Rotavirus Vaccine
Additional items found! 6

Members Archive contains
6 additional stories matching:
HPV Vaccine
(Password required)
HPV Vaccine
(Password required)